Skip to Content
Merck
CN

H2913

Monoclonal Anti-Histone Deacetylase 11 (HDAC11) antibody produced in mouse

clone HDAC11-31, purified immunoglobulin, buffered aqueous solution

Synonym(s):

Anti-HDAC11

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

UNSPSC Code:
12352203
MDL number:
MFCD06202148

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

mouse

conjugate

unconjugated

antibody form

purified immunoglobulin

clone

HDAC11-31, monoclonal

form

buffered aqueous solution

mol wt

antigen ~39 kDa

species reactivity

human

technique(s)

indirect ELISA: suitable, microarray: suitable, western blot: 2-4 μg/mL using HeLa cell extracts

isotype

IgG2b

shipped in

dry ice

storage temp.

−20°C

Gene Information

human ... HDAC11(79885)
mouse ... Hdac11(232232)
rat ... Hdac11(297453)

Immunogen

synthetic peptide corresponding to amino acids 2-16 of human HDAC11, conjugated to KLH. The HDAC11 sequence in mouse and rat differs by three amino acids.

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Storage Class

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
014K4789

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Annunziata Gloghini et al.
British journal of haematology, 147(4), 515-525 (2009-09-25)
Unselective histone deacetylase (HDAC) inhibitors are a promising novel therapy for lymphoid malignancies. However, these treatments remain empiric as the pattern of HDAC enzymes in different types of cancer, including lymphoid malignancies, remains unknown. We examined the expression of class

Related Content

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service